Search results
Zai La is an innovative, research-based, commercial stage biopharmaceutical company based in China and the U.S. focused on bringing transformative medicines for oncology, autoimmune disorders, infectious diseases and neurological disorders to patients in China and around the world.
2 days ago · ### Chapter 291: Lao Zai is Playing with Something New. Unlike EA's approach, Ubisoft did not bombard the market with trailers. They chose to wait until the game was released to make a stunning impact. However, during the game's development, they encountered some issues and needed Lao Zai to provide guidance. "What updates?"
3 days ago · Zai Lab Ltd is a holding company mainly engaged in the biopharmaceutical field. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that...
Jun 27, 2024 · Several executives at Zai Lab Ltd have recently sold shares of the company, according to SEC Form 4 filings. Chen Yajing, the Chief Financial Officer, sold 2,154 American Depositary Shares at a price of $17.901 per share, totaling $38,558. Following this transaction, Chen directly owns 13,714 share….
Jul 12, 2024 · Zai Lab Ltd is a holding company mainly engaged in the biopharmaceutical field. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including oncology, autoimmune and infectious diseases fields.
Jun 30, 2024 · Zai Lab Ltd is a holding company mainly engaged in the biopharmaceutical field. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including oncology, autoimmune and infectious diseases fields.
Jul 11, 2024 · Zai Lab Ltd is a holding company mainly engaged in the biopharmaceutical field. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that...
